Academic application of Good Cell Culture Practice for induced pluripotent stem cells.


Journal

ALTEX
ISSN: 1868-8551
Titre abrégé: ALTEX
Pays: Germany
ID NLM: 100953980

Informations de publication

Date de publication:
2021
Historique:
received: 22 01 2021
accepted: 29 04 2021
entrez: 8 5 2021
pubmed: 9 5 2021
medline: 28 10 2021
Statut: ppublish

Résumé

Human induced pluripotent stem cells (hiPSC) are a promising tool for replacing animal-based experiments. To warrant data reproducibility, quality-controlled research material is recommended. While the need for global harmonization of quality standards for stem cell banking centers, commercial providers, pre-clinical and clinical use of cells is well doc­umented, there are no recommendations available for quality control of hiPSC in an academic research environment to date. To fill this gap, we here give an example of a quality-controlled, two-tiered banking process producing a fully characterized master cell bank (MCB) and partially characterized respective working cell banks (WCB). Characteri­zation includes the study of morphology, mycoplasma contamination, cell line identity, karyotype stability, cell antigen expression and viability, gene expression, pluripotency, and post-thaw recovery. Costs of these procedures are cal­culated. We present the results of the proposed testing panel of two hiPSC MCBs and show that both fulfil the defined specifications regarding the above-mentioned characterization assays during and upon banking. In conclusion, we propose a panel of eight assays, which are practical and useful for an academic research laboratory working with hiPSCs. Meeting these proposed specifications ensures the quality of pluripotent stem cells throughout diverse experi­ments at moderate costs.

Identifiants

pubmed: 33963415
doi: 10.14573/altex.2101221
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

595-614

Auteurs

Julia Tigges (J)

IUF-Leibniz Research Institute for Environmental Medicine, Duesseldorf, Germany.

Kevin Bielec (K)

IUF-Leibniz Research Institute for Environmental Medicine, Duesseldorf, Germany.

Gabriele Brockerhoff (G)

IUF-Leibniz Research Institute for Environmental Medicine, Duesseldorf, Germany.

Barbara Hildebrandt (B)

Institute of Human Genetics, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany.

Ulrike Hübenthal (U)

IUF-Leibniz Research Institute for Environmental Medicine, Duesseldorf, Germany.

Julia Kapr (J)

IUF-Leibniz Research Institute for Environmental Medicine, Duesseldorf, Germany.

Katharina Koch (K)

IUF-Leibniz Research Institute for Environmental Medicine, Duesseldorf, Germany.

Nadine Teichweyde (N)

IUF-Leibniz Research Institute for Environmental Medicine, Duesseldorf, Germany.

Dagmar Wieczorek (D)

Institute of Human Genetics, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany.

Andrea Rossi (A)

IUF-Leibniz Research Institute for Environmental Medicine, Duesseldorf, Germany.

Ellen Fritsche (E)

IUF-Leibniz Research Institute for Environmental Medicine, Duesseldorf, Germany.
Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH